StablevaX™ is a novel technology that aims to produce Fridge Free vaccines to eliminate the need for the Cold Chain, reduce vaccine wastage and save lives.
Did you know that fridge-free vaccines reduce the CO2 footprint of the cold-chain and eliminate the need for refrigeration? See our CEO & Exective Director, Özgür Tuncer, explain the benefits and impact of fridge-free vaccines. https://t.co/Z4LzxD9Ohu
#vaccines#ceo#fridgefree
Did you know that The Fridge-free vaccine company has identified more than 60 vaccines that could be converted to fridge-free status?
#vaccines#innovations#fridgegfree#COVID19
https://t.co/gMbrQsQW6V
Stablepharma are delighted, that in partnership with BB-NCIPD Ltd. (Bul Bio), we have established thermostability of StablevaX™-Td Vaccine following exposure of the vaccine to +45°C for 12 months during animal challenge studies. https://t.co/vm3mUNeCvm
#vaccineswork#COVID
Özgür Tuncer, CEO & Executive Director, was delighted to present Stablepharma's campaign pitch https://t.co/h64hkEnMeA at Crowdcube’s first LIVE investor event since the pandemic. It was a packed audience of well-known European tech brands & 100s of HNW investors. #vaccines
Stablepharma Public Crowdfunding is now 94% funded!
We are just a few days into our second crowdfunding campaign on Crowdcube https://t.co/h64hkEnMeA & we have already achieved 94% of our £3m target! Thank you for al of your support. Capital at risk #Vaccine#COVID19#investment
We are delighted to be one of the HOT NEW ARRIVALS on Crowdcube's platform. After just 2 days into our public crowdfunding round we are 93% funded! Great news!
https://t.co/pfBltT5163
#vaccine#investment#Covid_19#stablepharma
Stablepharma Public Crowdfunding is now live!
Following the success of our last crowdfunding campaign, the Stablepharma team are excited to announce that we have launched our second crowdfunding campaign on Crowdcube https://t.co/h64hkEnMeA
We are 93% funded!
Capital at Risk
What would eliminating the need for the cold-chain / refrigeration of vaccines mean to humanity? Reducing child deaths from vaccines preventable diseases, reducing vaccine wastage and the CO2 emissions of cold storage.
https://t.co/7XAO8qRqlc
#vaccine#VaccineDeaths#COVID19
Welcome to new BIA members @Stablepharma1 🎉
Stablepharma have patented a novel technology to improve healthcare for those most at risk of death and disability caused by vaccine preventable diseases 💉
Want to find out more? 👇
https://t.co/JzC3CvcRE7
4️⃣ Özgür Tuncer is presenting #StablevaX by @Stablepharma1, a novel technology that aims to produce Fridge Free vaccines to eliminate the need for the Cold Chain, reduce vaccine wastage and save lives. #bioProcessUK
We are delighted that our CEO & Executive Director of Stablepharma, Özgür Tuncer will be presenting our novel StablevaX™ technology in this year's Dragon's Den session at the BioIndustry Association Annual #bioProcessUK Conference 23-25 Nov 2021.
https://t.co/DWwKikJSAC
Stablepharma completes the first close of Series A raise with £2 million (~$2.8 million) following a number of high-profile partnership announcements
https://t.co/yzkoRFCfkh #COVID19#VaccinesWork#Vaccines#innovation